Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elotuzumab in multiple myeloma.
Bruzzese A, Martino EA, Vigna E, Iaccino E, Mendicino F, Lucia E, Olivito V, Filippelli G, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: filippelli g. Expert Opin Biol Ther. 2023 Jan;23(1):7-10. doi: 10.1080/14712598.2022.2145882. Epub 2022 Nov 14. Expert Opin Biol Ther. 2023. PMID: 36373842 No abstract available.
Iron chelation therapy.
Bruzzese A, Martino EA, Mendicino F, Lucia E, Olivito V, Bova C, Filippelli G, Capodanno I, Neri A, Morabito F, Gentile M, Vigna E. Bruzzese A, et al. Among authors: filippelli g. Eur J Haematol. 2023 May;110(5):490-497. doi: 10.1111/ejh.13935. Epub 2023 Feb 8. Eur J Haematol. 2023. PMID: 36708354 Review.
Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period.
Bruzzese A, Vigna E, Martino EA, Mendicino F, Lucia E, Olivito V, Mazzulla R, De Rose S, Cozza PP, Bova C, Filippelli G, Zinno F, Morelli M, Morabito F, Gentile M. Bruzzese A, et al. Among authors: filippelli g. Blood Coagul Fibrinolysis. 2023 Apr 1;34(3):215-217. doi: 10.1097/MBC.0000000000001186. Epub 2022 Nov 29. Blood Coagul Fibrinolysis. 2023. PMID: 36730001
Myelodysplastic syndromes with ring sideroblasts.
Bruzzese A, Vigna E, Martino EA, Mendicino F, Lucia E, Olivito V, Bova C, Barbato A, Filippelli G, Capodanno I, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: filippelli g. Hematol Oncol. 2023 Oct;41(4):612-620. doi: 10.1002/hon.3125. Epub 2023 Feb 26. Hematol Oncol. 2023. PMID: 36794650 Review.
Acalabrutinib in chronic lymphocytic leukemia.
Martino EA, Bruzzese A, Vigna E, Iaccino E, Mendicino F, Lucia E, Olivito V, Filippelli G, Neri A, Morabito F, Gentile M. Martino EA, et al. Among authors: filippelli g. Expert Opin Pharmacother. 2023 Apr;24(5):545-549. doi: 10.1080/14656566.2023.2194486. Epub 2023 Mar 23. Expert Opin Pharmacother. 2023. PMID: 36943916 No abstract available.
Safety and Tolerability of Antimicrobial Agents in the Older Patient.
Soraci L, Cherubini A, Paoletti L, Filippelli G, Luciani F, Laganà P, Gambuzza ME, Filicetti E, Corsonello A, Lattanzio F. Soraci L, et al. Among authors: filippelli g. Drugs Aging. 2023 Jun;40(6):499-526. doi: 10.1007/s40266-023-01019-3. Epub 2023 Mar 28. Drugs Aging. 2023. PMID: 36976501 Free PMC article. Review.
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway.
Cirillo F, Talia M, Santolla MF, Pellegrino M, Scordamaglia D, Spinelli A, De Rosis S, Giordano F, Muglia L, Zicarelli A, Di Dio M, Rigiracciolo DC, Miglietta AM, Filippelli G, De Francesco EM, Belfiore A, Lappano R, Maggiolini M. Cirillo F, et al. Among authors: filippelli g. Cell Death Discov. 2023 Sep 26;9(1):353. doi: 10.1038/s41420-023-01654-0. Cell Death Discov. 2023. PMID: 37749101 Free PMC article.
Validation of a low-cost lead hazard screening kit for the home environment.
Wicks A, Joseph O, Keranen J, Herrmann A, Lieberman M, Peaslee GF, Sisk ML, Filippelli G, Beidinger-Burnett H. Wicks A, et al. Among authors: filippelli g. Integr Environ Assess Manag. 2024 May 2. doi: 10.1002/ieam.4934. Online ahead of print. Integr Environ Assess Manag. 2024. PMID: 38695667
92 results